Personalized medicine hits primary practice as genetic testing is being done for the first time in family practice to better select psychiatric medications for patients: an interview with Dr. Nicholas Voudouris
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
For the first time in Canada, genetic testing done at the
Centre for Addiction and Mental Health (CAMH) in Toronto is
being made available to family physicians. This leading-edge research
started just over a year ago at the Thornhill Medical Centre
in Thornhill, Ontario. The aim of the research is to use genetic
testing to better select psychiatric drugs and dosages to improve
efficacy and reduce side effects in patients suffering from mental
illness. Dr. Nicholas Voudouris, a family physician at the Thornhill
Medical Centre who is heavily involved in this project, describes
it as leading-edge science that has the possibility of having profound
impact on personalized medicine at the primary care level.
I spoke with Dr. Voudouris to learn more about him, this project,
and the future implications genetic testing could have on personalized
medicine and reducing health care spending.
Description
Keywords
Personalized Medicine, Pharmacogenetics, Mental Illness, Psychiatric Medications, Genetic Testing
Citation
UOJM 4(1):21-23
